Search companies

A directory of companies

Cercle is an AI technology company with the mission to advance healthcare for all women. With AI, we harness anonymized, diverse and reliable biomedical and genomics data from around the world to deliver unprecedented and secure healthcare insights. The Cercle™ Biomedical Graph is a first-of-its-kind knowledge graph. It uses AI to analyze billions of anonymized data points securely drawn from hospitals, clinics and research labs from all over the globe. We’re turning raw, unstructured and disconnected biomedical and genomics data into clear insights for doctors, hospitals, research centers, pharmaceutical companies, labs and clinics so they can treat patients more effectively. That’s how we support innovation and advancements in treatments and healthcare outcomes across the entire healthcare ecosystem. Women's health is the most underserved healthcare market, which is why Cercle's first focus will be fertility and IVF. We’re proud to beta launch Luce, a fertility companion for women and doctors that analyzes data from thousands of treatment cycles to help people make more informed decisions for their fertility journeys. Cercle’s suite of products includes: — Data access tools: Researchers and lab directors can query and visualize structured biomedical and genomics data to accelerate health innovation. — Modeling and insights products: Advanced modeling tools help healthcare providers with financial and operational strategies. — Tools for clinicians: Doctors get personalized care insights and predictive treatment outcomes based on Real World Data and Real World Evidence. — Patient companions: Patients get clear, data-driven insights that make it easier to understand their health and make informed decisions with their doctors. Cercle is built by medical professionals, molecular biologists, data scientists, engineers and business entrepreneurs dedicated to unlocking a world where everyone feels informed, empowered, and in control of their own health.
At mProbe we are transforming the fields of precision health and precision medicine with molecular diagnostic tools and analysis to improve disease risk screening and intervention effectiveness when compared to the current standards of care. Clinical outcomes matter most, but biology changes first. We have harnessed the ability to measure changes at the systems biology level so that disease onset, progression and care efficacy can be determined long before other clinical indicators- like weight loss, blood pressure, even blood chemistry - change. Our molecular tests facilitate the choice of optimized interventions based upon patient’s risk and matched to the individual’s biology providing the highest likelihood of success. mProbe utilizes our proprietary technology combination of artificial intelligence and multi-omic diagnostics to predict, prevent and cure disease precisely. mProbe has developed four product lines encompassing Precision Cancer Care, Precision Maternal/Child Care, Precision Health and Wellness, and Healthcare Analytics. In Precision Cancer Care we help oncologists choose the most efficacious chemotherapies and targeted therapies based on the individual’s tumor biology. In Precision Maternal/Child Care, we measure healthy pregnancy progression and predict preterm birth and preeclampsia allowing families and their physicians to take preventive steps. We also provide precision diagnostics for diseases such as Kawasaki Diseases, etc. In Precision Health and Wellness, we predict chronic diseases and their complications with absolute probabilities enabling physicians and patients to take the necessary preventive steps. In Healthcare Analytics, through HBI Solutions'​ state of art machine learning and artificial intelligence, we offer breakthrough predictive risk technologies, cost reduction and quality measurement solutions to hospitals, pharmaceutical companies, regional health systems, and insurance companies
599 / 3319